EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitLeitlinieOpen Access · CC BY-NC 4.0

Clinical Practice Guideline for Blood-based Circulating Tumor DNA Assays

Jee-Soo Lee iD, Eun Hye Cho iD, Boram Kim iD, Jinyoung Hong iD, Young-Gon Kim iD, Yoonjung Kim iD, Ja-Hyun Jang iD, Seung-Tae Lee iD, Sun-Young Kong iD, Woochang Lee iD, Saeam Shin iD, Eun Young Song iD und 1 weitere

Annals of Laboratory Medicine · 01.05.2024 · 44 (3) · 195-209

DOI: 10.3343/alm.2023.0389 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Annals of Laboratory Medicine, online erschienen am 15.01.2024. Verfasst von Jee-Soo Lee und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Circulating Tumor DNA. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Circulating Tumor DNAHumansBiomarkers, TumorPrognosisNeoplasm, ResidualMutationHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

Cell-free nucleic acidCirculating tumor DNAGuidelineHigh-throughput nucleotide sequencing

Substanzen

Circulating Tumor DNABiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • Department of Laboratory Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Samkwang Medical Laboratories, Seoul, Korea.
  • Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.
  • Dxome Co. Ltd., Seongnam, Korea.

ORCID-Profile: Jee-Soo Lee, Eun Hye Cho, Boram Kim, Jinyoung Hong, Young-Gon Kim, Yoonjung Kim, Ja-Hyun Jang, Seung-Tae Lee, Sun-Young Kong, Woochang Lee, Saeam Shin, Eun Young Song

Zitieren

APA

Lee, J. S., Cho, E. H., Kim, B., Hong, J., Kim, Y. G., Kim, Y., Jang, J. H., Lee, S. T., Kong, S. Y., Lee, W., Shin, S., Song, E. Y., & Clinical Practice Guidelines Committee of the Korean Society for Laboratory Medicine (2024). Clinical Practice Guideline for Blood-based Circulating Tumor DNA Assays. Annals of Laboratory Medicine, 44(3), 195-209. https://doi.org/10.3343/alm.2023.0389

Vancouver

Lee JS, Cho EH, Kim B, Hong J, Kim YG, Kim Y, et al. Clinical Practice Guideline for Blood-based Circulating Tumor DNA Assays. Annals of Laboratory Medicine. 2024;44(3):195-209. doi:10.3343/alm.2023.0389

BibTeX
@article{Lee2024,
  author = {Lee, Jee-Soo and Cho, Eun Hye and Kim, Boram and Hong, Jinyoung and Kim, Young-Gon and Kim, Yoonjung and Jang, Ja-Hyun and Lee, Seung-Tae and Kong, Sun-Young and Lee, Woochang and Shin, Saeam and Song, Eun Young and Clinical Practice Guidelines Committee of the Korean Society for Laboratory Medicine, Clinical Practice Guidelines Committee of the Korean Society for Laboratory Medicine},
  title = {Clinical Practice Guideline for Blood-based Circulating Tumor DNA Assays},
  journal = {Annals of Laboratory Medicine},
  year = {2024},
  volume = {44},
  number = {3},
  pages = {195--209},
  doi = {10.3343/alm.2023.0389}
}
Kostenlos starten →